Evidence map›Paper›PMID 30349740›Full record

ArticleInternational journal of retina and vitreous2018

Subconjunctival 0.1% epinephrine versus placebo in maintenance of mydriasis during vitrectomy: a randomized controlled trial.

Rafael B de Araújo, Breno M S Azevedo, Thais S Andrade, Maria F Abalem, Mário L R Monteiro, Pedro C Carricondo

Open access · goldAbstract read
In one paragraph

Article in International journal of retina and vitreous, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Urrets-Zavalia syndrome following placement of scleral-sutured intraocular lens.American journal of ophthalmology case reports · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rafael B de Araújo1Division of Ophthalmology, Hospital Universitário Onofre Lopes, Universidade Federal do Rio Grande do Norte, Rua Mipibu, 741 apt 1402A, Natal, RN 59014-480 Brazil.
Breno M S Azevedo2Division of Ophthalmology, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo, Rua Dr. Ovídio Pires de Campos, 225, 05403-010 São Paulo, SP Brazil.
Thais S Andrade2Division of Ophthalmology, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo, Rua Dr. Ovídio Pires de Campos, 225, 05403-010 São Paulo, SP Brazil.
Maria F Abalem2Division of Ophthalmology, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo, Rua Dr. Ovídio Pires de Campos, 225, 05403-010 São Paulo, SP Brazil.
Mário L R Monteiro2Division of Ophthalmology, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo, Rua Dr. Ovídio Pires de Campos, 225, 05403-010 São Paulo, SP Brazil.
Pedro C Carricondo2Division of Ophthalmology, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo, Rua Dr. Ovídio Pires de Campos, 225, 05403-010 São Paulo, SP Brazil.
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRUniversidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPupil dilation and mydriasis maintenance throughout vitreoretinal surgeries are important to allow satisfactory fundus visualization and reduce risk of complications. The purpose of this study is to evaluate the role of subconjunctival epinephrine 0.1% injection in mydriasis maintenance during vitrectomy.

methodsNinety-nine consecutive patients undergoing vitrectomy were enrolled. All subjects were preoperatively dilated with tropicamide 1%. Each patient was randomly allocated either in the epinephrine or placebo group. In epinephrine group, patients were submitted to a 0.2 cc subconjunctival injection of a 0.1% epinephrine solution just before first incisions. In placebo group, the same procedure was performed with 0.2 cc of saline 0.9%. Horizontal pupil diameter was measured with calipers before and in the end of the procedure.

resultsPatients in the epinephrine group showed a significantly larger mean pupil diameter in the end of the surgery compared to placebo. There was a significant increase of mean pupil diameter from the beginning to the end of the surgery in such patients. Blood pressure was significantly higher in the epinephrine group than in placebo group. No other adverse effects were noted.

conclusionSubconjunctival epinephrine is effective for maintaining and increasing pupil size during vitrectomy, compared to placebo. Caution should be taken regarding intraoperative blood pressure levels.

trial registrationRBR; RBR-3qzhvg; Registered 8 May 2018-Retrospectively registered, http://www.ensaiosclinicos.gov.br/rg/RBR-3qzhvg/.

Indexed as

EpinephrineMydriasisPupilVitrectomy

Identifiers

PMID30349740
PMCPMC6192114
OpenAlexW2896843000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.